المؤلفون: Brandenburg A; Medical Clinic III of Oncology, Hematology, Rheumatology and Immune-Oncology, University Hospital Bonn, Venusberg Campus 1, 53127 Bonn, Germany., Heine A; Medical Clinic III of Oncology, Hematology, Rheumatology and Immune-Oncology, University Hospital Bonn, Venusberg Campus 1, 53127 Bonn, Germany., Brossart P; Medical Clinic III of Oncology, Hematology, Rheumatology and Immune-Oncology, University Hospital Bonn, Venusberg Campus 1, 53127 Bonn, Germany. Electronic address: Peter.Brossart@ukbonn.de.

المصدر: Trends in cancer [Trends Cancer] 2024 Aug; Vol. 10 (8), pp. 749-769. Date of Electronic Publication: 2024 Jul 23.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Cell Press Country of Publication: United States NLM ID: 101665956 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2405-8025 (Electronic) Linking ISSN: 24058025 NLM ISO Abbreviation: Trends Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Cancer Vaccines*/therapeutic use , Cancer Vaccines*/immunology , Cancer Vaccines*/administration & dosage , Neoplasms*/therapy , Neoplasms*/immunology , Immune Checkpoint Inhibitors*/therapeutic use , Immune Checkpoint Inhibitors*/pharmacology , Immunotherapy*/methods , Immunotherapy*/trends, Humans ; Animals ; Antigens, Neoplasm/immunology ; Immunotherapy, Adoptive/methods ; Immunotherapy, Adoptive/adverse effects ; Combined Modality Therapy/methods ; Adoptive Transfer/methods

المؤلفون: Martino M; Stem Cell Transplantation and Cellular Therapies Unit (CTMO), Grande Ospedale Metropolitano 'Bianchi-Melacrino-Morelli', Reggio Calabria, Italy., Gamberi B; Azienda USL - IRCCS di Reggio Emilia, Reggio Emilia, Reggio Emilia, Italy., Antonioli E; Hematology Department, Careggi Hospital, Florence, Italy., Aquino S; Hematology and Hematopoietic Stem Cell Transplantation Unit, IRCCS Ospedale Policlinico San Martino, Genoa, Italy., Della Pepa R; Hematology Unit, Department of Clinical Medicine and Surgery, University of Naples 'Federico II', Naples, Italy., Malerba L; Haematology and Haematopoietic Stem Cell Transplant Center, AST, Pesaro Urbino, Pesaro, Italy., Mangiacavalli S; Division of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy., Pezzatti S; Department of Haematology, San Gerardo Hospital, Monza, MB, Italy., Bringhen S; SSD Clinical trial in oncoematologia e mieloma multiplo, Dipartimento di Oncologia, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Torino, Italy., Zamagni E; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia 'Seràgnoli', Bologna, Italy.; Dipartimento di Scienze Mediche e Chirurgiche, Università di Bologna, Bologna, Italy.

المصدر: Expert review of hematology [Expert Rev Hematol] 2024 Jul; Vol. 17 (7), pp. 375-390. Date of Electronic Publication: 2024 May 21.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Taylor & Francis Country of Publication: England NLM ID: 101485942 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1747-4094 (Electronic) Linking ISSN: 17474094 NLM ISO Abbreviation: Expert Rev Hematol Subsets: MEDLINE

مواضيع طبية MeSH: Antibodies, Bispecific*/therapeutic use , Immunotherapy, Adoptive*/methods , Immunotherapy, Adoptive*/adverse effects , Multiple Myeloma*/therapy , Multiple Myeloma*/immunology , B-Cell Maturation Antigen*/immunology , B-Cell Maturation Antigen*/antagonists & inhibitors, Humans ; Receptors, Chimeric Antigen/immunology ; Receptors, Chimeric Antigen/therapeutic use ; Immunotherapy/methods ; T-Lymphocytes/immunology

المؤلفون: Mishra HK; Cellinfinitybio, San Francisco, CA 94107, USA., Kalyuzhny A; Biotechne 2, Minneapolis, MN 55413, USA.

المصدر: Cells [Cells] 2024 Sep 10; Vol. 13 (18). Date of Electronic Publication: 2024 Sep 10.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101600052 Publication Model: Electronic Cited Medium: Internet ISSN: 2073-4409 (Electronic) Linking ISSN: 20734409 NLM ISO Abbreviation: Cells Subsets: MEDLINE

مواضيع طبية MeSH: Neoplasms*/therapy , Neoplasms*/immunology , Induced Pluripotent Stem Cells*/immunology , Induced Pluripotent Stem Cells*/cytology , Receptors, Chimeric Antigen*/immunology , Immunotherapy, Adoptive*/methods , T-Lymphocytes*/immunology, Humans ; Immunotherapy/methods ; Animals

المؤلفون: McErlean EM; School of Pharmacy, Queen's University of Belfast, 97 Lisburn Road, Belfast, BT9 7BL, UK. e.mcerlean@qub.ac.uk., McCarthy HO; School of Pharmacy, Queen's University of Belfast, 97 Lisburn Road, Belfast, BT9 7BL, UK.; School of Chemical Sciences, Dublin City University, Collins Avenue, Dublin 9, Ireland.; Biodesign Europe, Dublin City University, Dublin 9, Ireland.

المصدر: Journal of nanobiotechnology [J Nanobiotechnology] 2024 Sep 10; Vol. 22 (1), pp. 552. Date of Electronic Publication: 2024 Sep 10.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 101152208 Publication Model: Electronic Cited Medium: Internet ISSN: 1477-3155 (Electronic) Linking ISSN: 14773155 NLM ISO Abbreviation: J Nanobiotechnology Subsets: MEDLINE

مواضيع طبية MeSH: Killer Cells, Natural*/immunology , Receptors, Chimeric Antigen*/genetics , Gene Transfer Techniques* , Immunotherapy, Adoptive*/methods , Cell Engineering*/methods, Humans ; Animals ; Nanoparticles/chemistry ; Neoplasms/therapy ; Neoplasms/immunology ; Electroporation/methods ; Immunotherapy/methods

المؤلفون: Feng F; Department of Neurosurgery, Qilu Hospital and Institute of Brain and Brain-Inspired Science, Cheeloo College of Medicine, Shandong University, 107 Wenhua Xi Road, Jinan, 250012, Shandong, China., Shen J; Department of Neurosurgery, Qilu Hospital and Institute of Brain and Brain-Inspired Science, Cheeloo College of Medicine, Shandong University, 107 Wenhua Xi Road, Jinan, 250012, Shandong, China., Qi Q; Department of Neurosurgery, Qilu Hospital and Institute of Brain and Brain-Inspired Science, Cheeloo College of Medicine, Shandong University, 107 Wenhua Xi Road, Jinan, 250012, Shandong, China., Zhang Y; Department of Neurosurgery, Qilu Hospital and Institute of Brain and Brain-Inspired Science, Cheeloo College of Medicine, Shandong University, 107 Wenhua Xi Road, Jinan, 250012, Shandong, China., Ni S; Department of Neurosurgery, Qilu Hospital and Institute of Brain and Brain-Inspired Science, Cheeloo College of Medicine, Shandong University, 107 Wenhua Xi Road, Jinan, 250012, Shandong, China.

المصدر: Theranostics [Theranostics] 2024 Sep 03; Vol. 14 (14), pp. 5725-5742. Date of Electronic Publication: 2024 Sep 03 (Print Publication: 2024).

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Ivyspring International Publisher Country of Publication: Australia NLM ID: 101552395 Publication Model: eCollection Cited Medium: Internet ISSN: 1838-7640 (Electronic) Linking ISSN: 18387640 NLM ISO Abbreviation: Theranostics Subsets: MEDLINE

مواضيع طبية MeSH: Brain Neoplasms*/therapy , Brain Neoplasms*/immunology , Receptors, Chimeric Antigen*/immunology , Tumor Microenvironment*/immunology , Immunotherapy, Adoptive*/methods , Macrophages*/immunology, Humans ; Animals ; Tumor-Associated Macrophages/immunology ; Tumor-Associated Macrophages/metabolism ; T-Lymphocytes/immunology ; Immunotherapy/methods

المؤلفون: Heidarnejad K; Department of Immunology, Shiraz University of Medical Sciences, Shiraz, Iran., Nooreddin Faraji S; Department of Pathology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran. Electronic address: farajisn@sums.ac.ir., Mahfoozi S; Department of Immunology, Shiraz University of Medical Sciences, Shiraz, Iran., Ghasemi Z; Department of Immunology, Shiraz University of Medical Sciences, Shiraz, Iran., Sadat Dashti F; Reproductive Immunology Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran., Asadi M; School of Advanced Medical Sciences and Technologies, Shiraz University of Medical Sciences, Shiraz, Iran., Ramezani A; Shiraz Institute for Cancer Research, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran; Department of Medical Biotechnology, School of Advanced Medical Sciences and Technologies, Shiraz University of Medical Sciences, Shiraz, Iran. Electronic address: aramezani@sums.ac.ir.

المصدر: Human immunology [Hum Immunol] 2024 Sep; Vol. 85 (5), pp. 111090. Date of Electronic Publication: 2024 Aug 29.

نوع المنشور: Journal Article; Systematic Review; Review

بيانات الدورية: Publisher: Elsevier/North-Holland Country of Publication: United States NLM ID: 8010936 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-1166 (Electronic) Linking ISSN: 01988859 NLM ISO Abbreviation: Hum Immunol Subsets: MEDLINE

مواضيع طبية MeSH: Single-Chain Antibodies*/immunology , Single-Chain Antibodies*/therapeutic use , Breast Neoplasms*/therapy , Breast Neoplasms*/immunology , Immunotherapy*/methods, Humans ; Female ; Antigens, Neoplasm/immunology ; Receptors, Chimeric Antigen/immunology ; Receptors, Chimeric Antigen/genetics ; Immunotherapy, Adoptive/methods ; Animals

المؤلفون: Maccagno M; Department of Molecular Biotechnology and Health Sciences, 10126 Turin, Italy.; Molecular Biotechnology Centre, University of Torino, 10126 Turin, Italy., Tapparo M; Molecular Biotechnology Centre, University of Torino, 10126 Turin, Italy.; Department of Medical Sciences, University of Torino, 10126 Turin, Italy., Saccu G; Molecular Biotechnology Centre, University of Torino, 10126 Turin, Italy.; Department of Medical Sciences, University of Torino, 10126 Turin, Italy., Rumiano L; Department of Molecular Biotechnology and Health Sciences, 10126 Turin, Italy.; Molecular Biotechnology Centre, University of Torino, 10126 Turin, Italy., Kholia S; Molecular Biotechnology Centre, University of Torino, 10126 Turin, Italy.; Department of Medical Sciences, University of Torino, 10126 Turin, Italy., Silengo L; Molecular Biotechnology Centre, University of Torino, 10126 Turin, Italy., Herrera Sanchez MB; Molecular Biotechnology Centre, University of Torino, 10126 Turin, Italy.; 2i3T, Società per la Gestione dell'incubatore di Imprese e per il Trasferimento Tecnologico, University of Torino, 10126 Turin, Italy.

المصدر: Medical sciences (Basel, Switzerland) [Med Sci (Basel)] 2024 Aug 28; Vol. 12 (3). Date of Electronic Publication: 2024 Aug 28.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101629322 Publication Model: Electronic Cited Medium: Internet ISSN: 2076-3271 (Electronic) Linking ISSN: 20763271 NLM ISO Abbreviation: Med Sci (Basel) Subsets: MEDLINE

مواضيع طبية MeSH: Neoplasms*/therapy , Immunotherapy*, Humans ; Cancer Vaccines ; Immunotherapy, Adoptive ; Nanoparticles ; Animals ; T-Lymphocytes/immunology

المؤلفون: Rehman M; Molecular Virology Lab, Atta-Ur-Rahman School of Applied Biosciences, National University of Sciences and Technology, Islamabad, Pakistan., Qaiser A; Molecular Virology Lab, Atta-Ur-Rahman School of Applied Biosciences, National University of Sciences and Technology, Islamabad, Pakistan., Khan HS; Molecular Virology Lab, Atta-Ur-Rahman School of Applied Biosciences, National University of Sciences and Technology, Islamabad, Pakistan., Manzoor S; Molecular Virology Lab, Atta-Ur-Rahman School of Applied Biosciences, National University of Sciences and Technology, Islamabad, Pakistan., Ashraf J; Institute of Dentistry, University of Eastern Finland, Kuopio, Finland. Javeda@student.uef.fi.; Riphah International University, Islamabad, Pakistan. Javeda@student.uef.fi.

المصدر: Clinical and experimental medicine [Clin Exp Med] 2024 Aug 06; Vol. 24 (1), pp. 180. Date of Electronic Publication: 2024 Aug 06.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Springer-Verlag Italia Country of Publication: Italy NLM ID: 100973405 Publication Model: Electronic Cited Medium: Internet ISSN: 1591-9528 (Electronic) Linking ISSN: 15918890 NLM ISO Abbreviation: Clin Exp Med Subsets: MEDLINE

مواضيع طبية MeSH: Neoplasms*/therapy , Neoplasms*/immunology , Immunotherapy, Adoptive*/methods , Receptors, Chimeric Antigen*/immunology, Humans ; Immunologic Factors/therapeutic use ; Immunomodulating Agents/therapeutic use ; Immunomodulating Agents/pharmacology ; T-Lymphocytes/immunology ; Immunotherapy/methods

المؤلفون: Liao CF; Department of Hematology, Key Laboratory of Hematology, The Second Affiliated Hospital of Nanchang University.Nanchang 330006, Jiangxi Province, China.; Medical College of Nanchang University, Nanchang 330006, Jiangxi Province, China., Lai HR; Department of Hematology, Key Laboratory of Hematology, The Second Affiliated Hospital of Nanchang University.Nanchang 330006, Jiangxi Province, China.; Medical College of Nanchang University, Nanchang 330006, Jiangxi Province, China., Li J; Department of Hematology, Key Laboratory of Hematology, The Second Affiliated Hospital of Nanchang University.Nanchang 330006, Jiangxi Province, China.E-mail: ndefy03048@ncu.edu.cn.

المصدر: Zhongguo shi yan xue ye xue za zhi [Zhongguo Shi Yan Xue Ye Xue Za Zhi] 2024 Aug; Vol. 32 (4), pp. 1290-1294.

نوع المنشور: Journal Article; Review; English Abstract

بيانات الدورية: Publisher: Zhongguo shi yan xue za zhi she Country of Publication: China NLM ID: 101084424 Publication Model: Print Cited Medium: Print ISSN: 1009-2137 (Print) Linking ISSN: 10092137 NLM ISO Abbreviation: Zhongguo Shi Yan Xue Ye Xue Za Zhi Subsets: MEDLINE

مواضيع طبية MeSH: Immunotherapy, Adoptive*/adverse effects , Tumor Microenvironment*, Humans ; Receptors, Chimeric Antigen ; Hematologic Neoplasms/therapy ; Cytokine Release Syndrome/therapy ; Cytokine Release Syndrome/etiology ; T-Lymphocytes ; Receptors, Antigen, T-Cell ; Immunotherapy/adverse effects

المؤلفون: Wang M; Key Laboratory of Organ Regeneration and Transplantation of Ministry of Education, First Hospital of Jilin University, Changchun, China.; National-Local Joint Engineering Laboratory of Animal Models for Human Disease, First Hospital of Jilin University, Changchun, China., Jia L; Department of General Medicine, Shanxi Province Cancer Hospital, Taiyuan, China., Dai X; Key Laboratory of Organ Regeneration and Transplantation of Ministry of Education, First Hospital of Jilin University, Changchun, China.; National-Local Joint Engineering Laboratory of Animal Models for Human Disease, First Hospital of Jilin University, Changchun, China., Zhang X; Key Laboratory of Organ Regeneration and Transplantation of Ministry of Education, First Hospital of Jilin University, Changchun, China.; National-Local Joint Engineering Laboratory of Animal Models for Human Disease, First Hospital of Jilin University, Changchun, China.

المصدر: Molecular oncology [Mol Oncol] 2024 Aug; Vol. 18 (8), pp. 1821-1848. Date of Electronic Publication: 2024 Mar 08.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: John Wiley & Sons, Inc Country of Publication: United States NLM ID: 101308230 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-0261 (Electronic) Linking ISSN: 15747891 NLM ISO Abbreviation: Mol Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Immunotherapy, Adoptive*/methods , Neoplasms*/therapy , Neoplasms*/immunology , Receptors, Chimeric Antigen*/immunology, Humans ; Animals ; Immunotherapy/methods ; T-Lymphocytes/immunology ; Combined Modality Therapy/methods ; Cancer Vaccines/therapeutic use ; Cancer Vaccines/immunology